8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Nov 15, 2023 · 2y ago · Accession 0001193125-23-277914
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- 8-K
- Filing date
- Nov 15, 2023
- Report date
- Nov 15, 2023
- Document
- d941656d8k.htm
- Size
- 162 KB